These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36322904)

  • 41. Factor VIIIa regulates substrate delivery to the intrinsic factor X-activating complex.
    Panteleev MA; Ananyeva NM; Greco NJ; Ataullakhanov FI; Saenko EL
    FEBS J; 2006 Jan; 273(2):374-87. PubMed ID: 16403024
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Substitution of Arg527 and Arg531 in factor VIII associated with mild haemophilia A: characterization in terms of subunit interaction and cofactor function.
    Celie PH; Van Stempvoort G; Jorieux S; Mazurier C; Van Mourik JA; Mertens K
    Br J Haematol; 1999 Sep; 106(3):792-800. PubMed ID: 10468875
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The C-terminal acidic region in the A1 domain of factor VIII facilitates thrombin-catalyzed activation and cleavage at Arg
    Nakajima Y; Nogami K
    J Thromb Haemost; 2021 Mar; 19(3):677-688. PubMed ID: 33369157
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Some human inhibitor antibodies interfere with factor VIII binding to factor IX.
    Zhong D; Saenko EL; Shima M; Felch M; Scandella D
    Blood; 1998 Jul; 92(1):136-42. PubMed ID: 9639509
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of the C2 domain of factor VIIIa in the assembly of factor-X activating complex on the platelet membrane.
    Ahmad SS; Walsh PN
    Biochemistry; 2005 Oct; 44(42):13858-65. PubMed ID: 16229474
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Update on factor (F) VIII structure and function-related hemostatic coagulation and its regulatory mechanism (s)].
    Nogami K
    Rinsho Ketsueki; 2021; 62(7):781-789. PubMed ID: 34349063
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structural investigation of zymogenic and activated forms of human blood coagulation factor VIII: a computational molecular dynamics study.
    Venkateswarlu D
    BMC Struct Biol; 2010 Feb; 10():7. PubMed ID: 20184747
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The interface between the EGF2 domain and the protease domain in blood coagulation factor IX contributes to factor VIII binding and factor X activation.
    Fribourg C; Meijer AB; Mertens K
    Biochemistry; 2006 Sep; 45(35):10777-85. PubMed ID: 16939230
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of residues Asn89, Ile90, and Val107 of the factor IXa second epidermal growth factor domain that are essential for the assembly of the factor X-activating complex on activated platelets.
    Yang X; Chang YJ; Lin SW; Walsh PN
    J Biol Chem; 2004 Nov; 279(45):46400-5. PubMed ID: 15328360
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mild hemophilia A caused by increased rate of factor VIII A2 subunit dissociation: evidence for nonproteolytic inactivation of factor VIIIa in vivo.
    Pipe SW; Eickhorst AN; McKinley SH; Saenko EL; Kaufman RJ
    Blood; 1999 Jan; 93(1):176-83. PubMed ID: 9864159
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interactions between residues 2228-2240 within factor VIIIa C2 domain and factor IXa Gla domain contribute to propagation of clot formation.
    Soeda T; Nogami K; Ogiwara K; Shima M
    Thromb Haemost; 2011 Nov; 106(5):893-900. PubMed ID: 21947241
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Non-antigen-contacting region of an asymmetric bispecific antibody to factors IXa/X significantly affects factor VIII-mimetic activity.
    Sampei Z; Igawa T; Soeda T; Funaki M; Yoshihashi K; Kitazawa T; Muto A; Kojima T; Nakamura S; Hattori K
    MAbs; 2015; 7(1):120-8. PubMed ID: 25524207
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Binding of coagulation factor IXa to procoagulant platelets revisited: Low affinity and interactions with other factors.
    Soloveva PA; Podoplelova NA; Panteleev MA
    Biochem Biophys Res Commun; 2024 Aug; 720():150099. PubMed ID: 38749192
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structural insights into the interaction of blood coagulation co-factor VIIIa with factor IXa: a computational protein-protein docking and molecular dynamics refinement study.
    Venkateswarlu D
    Biochem Biophys Res Commun; 2014 Sep; 452(3):408-14. PubMed ID: 25157807
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Domain organization of membrane-bound factor VIII.
    Stoilova-McPhie S; Lynch GC; Ludtke S; Pettitt BM
    Biopolymers; 2013 Jul; 99(7):448-59. PubMed ID: 23616213
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The molecular basis for cross-reacting material-positive hemophilia A due to missense mutations within the A2-domain of factor VIII.
    Amano K; Sarkar R; Pemberton S; Kemball-Cook G; Kazazian HH; Kaufman RJ
    Blood; 1998 Jan; 91(2):538-48. PubMed ID: 9427707
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acidic Region Residues 1680-1684 in the A3 Domain of Factor VIII Contain a Thrombin-Interactive Site Responsible for Proteolytic Cleavage at Arg1689.
    Nakajima Y; Minami H; Nogami K
    Thromb Haemost; 2021 Oct; 121(10):1274-1288. PubMed ID: 33592631
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enzymatically oxidized phospholipids restore thrombin generation in coagulation factor deficiencies.
    Slatter DA; Percy CL; Allen-Redpath K; Gajsiewicz JM; Brooks NJ; Clayton A; Tyrrell VJ; Rosas M; Lauder SN; Watson A; Dul M; Garcia-Diaz Y; Aldrovandi M; Heurich M; Hall J; Morrissey JH; Lacroix-Desmazes S; Delignat S; Jenkins PV; Collins PW; O'Donnell VB
    JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563336
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model.
    Kitazawa T; Igawa T; Sampei Z; Muto A; Kojima T; Soeda T; Yoshihashi K; Okuyama-Nishida Y; Saito H; Tsunoda H; Suzuki T; Adachi H; Miyazaki T; Ishii S; Kamata-Sakurai M; Iida T; Harada A; Esaki K; Funaki M; Moriyama C; Tanaka E; Kikuchi Y; Wakabayashi T; Wada M; Goto M; Toyoda T; Ueyama A; Suzuki S; Haraya K; Tachibana T; Kawabe Y; Shima M; Yoshioka A; Hattori K
    Nat Med; 2012 Oct; 18(10):1570-4. PubMed ID: 23023498
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High levels of factor VIII activity in patients with acquired hemophilia A in remission are associated with unusually low coagulation potentials.
    Shibasaki F; Takeyama M; Ogiwara K; Furukawa S; Nakajima Y; Shimonishi N; Nogami K
    Int J Hematol; 2023 May; 117(5):669-677. PubMed ID: 36607560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.